Format

Send to

Choose Destination
Clin Infect Dis. 2006 Jul 1;43(1):67-71. Epub 2006 May 24.

Role of US military research programs in the development of US Food and Drug Administration--approved antimalarial drugs.

Author information

1
Military Infectious Diseases Research Program, US Army Medical Research and Materiel Command, Fort Detrick, MD 21702-5012, USA. lynn.kitchen@amedd.army.mil

Abstract

US military physicians and researchers helped identify the optimum treatment dose of the naturally occurring compound quinine and collaborated with the pharmaceutical industry in the development and eventual US Food and Drug Administration approval of the synthetic antimalarial drugs chloroquine, primaquine, chloroquine-primaquine, sulfadoxine-pyrimethamine, mefloquine, doxycycline, halofantrine, and atovaquone-proguanil. Because malaria parasites develop drug resistance, the US military must continue to support the creation and testing of new drugs to prevent and treat malaria until an effective malaria vaccine is developed. New antimalarial drugs also benefit civilians residing in and traveling to malarious areas.

PMID:
16758420
DOI:
10.1086/504873
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center